All Stories

  1. Differential Immunomodulatory Properties of Langya and Nipah Virus Proteins
  2. Endosomal fusion of pH-dependent enveloped viruses requires ion channel TRPM7
  3. A Semiquantitative Protein-Fragment Complementation Assay to Study Protein-Protein Interactions of the Polymerase Complex in Cellula
  4. SARS-CoV-2 uses CD4 to infect T helper lymphocytes
  5. SARS-CoV-2 requires acidic pH to infect cells
  6. Visualizing molecular interactions that determine assembly of a bullet-shaped vesicular stomatitis virus particle
  7. BSL2-compliant lethal mouse model of SARS-CoV-2 and variants of concern to evaluate therapeutics targeting the Spike protein
  8. SARS-CoV-2 productively infects primary human immune system cells in vitro and in COVID-19 patients
  9. Defining the risk of SARS-CoV-2 variants on immune protection
  10. Longitudinal Study after Sputnik V Vaccination Shows Durable SARS-CoV-2 Neutralizing Antibodies and Reduced Viral Variant Escape to Neutralization over Time
  11. The Nucleocapsid of Paramyxoviruses: Structure and Function of an Encapsidated Template
  12. Nipah virus W protein harnesses nuclear 14-3-3 to inhibit NF-κB-induced proinflammatory response
  13. A class II MHC-targeted vaccine elicits immunity against SARS-CoV-2 and its variants
  14. Methylation of viral mRNA cap structures by PCIF1 attenuates the antiviral activity of interferon-β
  15. N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2
  16. Identification of SARS-CoV-2 spike mutations that attenuate monoclonal and serum antibody neutralization
  17. N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2
  18. Structure and function of negative-strand RNA virus polymerase complexes
  19. Structure of the Receptor Binding Domain of EnvP(b)1, an Endogenous Retroviral Envelope Protein Expressed in Human Tissues
  20. Landscape analysis of escape variants identifies SARS-CoV-2 spike mutations that attenuate monoclonal and serum antibody neutralization
  21. Replication-Competent Vesicular Stomatitis Virus Vaccine Vector Protects against SARS-CoV-2-Mediated Pathogenesis in Mice
  22. Neutralizing Antibody and Soluble ACE2 Inhibition of a Replication-Competent VSV-SARS-CoV-2 and a Clinical Isolate of SARS-CoV-2
  23. Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein
  24. Oligomerization of the Vesicular Stomatitis Virus Phosphoprotein Is Dispensable for mRNA Synthesis but Facilitates RNA Replication
  25. Structure of the Vesicular Stomatitis Virus L Protein in Complex with Its Phosphoprotein Cofactor
  26. The C Protein Is Recruited to Measles Virus Ribonucleocapsids by the Phosphoprotein
  27. Vesicular Stomatitis Virus Transcription Is Inhibited by TRIM69 in the Interferon-Induced Antiviral State
  28. Regulation of measles virus gene expression by P protein coiled-coil properties
  29. Comment la ré-initiation de la transcription est-elle gouvernée chez le virus de la rougeole ?
  30. Interference with the production of infectious viral particles and bimodal inhibition of replication are broadly conserved antiviral properties of IFITMs
  31. How order and disorder within paramyxoviral nucleoproteins and phosphoproteins orchestrate the molecular interplay of transcription and replication
  32. Measles virus infection of human keratinocytes: Possible link between measles and atopic dermatitis
  33. Modulation of Re-initiation of Measles Virus Transcription at Intergenic Regions by PXD to NTAIL Binding Strength
  34. HSP90 Chaperoning in Addition to Phosphoprotein Required for Folding but Not for Supporting Enzymatic Activities of Measles and Nipah Virus L Polymerases
  35. RIG-I Self-Oligomerization Is Either Dispensable or Very Transient for Signal Transduction
  36. Dissecting Virus Entry: Replication-Independent Analysis of Virus Binding, Internalization, and Penetration Using Minimal Complementation of β-Galactosidase
  37. Sequence of Events in Measles Virus Replication: Role of Phosphoprotein-Nucleocapsid Interactions